Quantcast
Last updated on April 24, 2014 at 12:48 EDT

Latest Insulin therapy Stories

2011-09-27 06:30:00

DANBURY, Conn., Sept. 27, 2011 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today announced top-line results from a Phase 1 clinical trial of BIOD-105 and BIOD-107 at Oregon Health and Sciences University to evaluate the pharmacokinetic, pharmacodynamic and infusion site tolerability profiles of these ultra-rapid-acting formulations of recombinant human insulin, relative to Humalog®,( )when delivered by insulin pumps. The trial was a single-center, randomized,...

2011-09-22 11:22:02

Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin The NHS has stumped up an extra £625 million over the past decade on synthetic forms of insulin, when the recommended human alternatives– which are considerably cheaper– would have probably been just as effective, reveals research published online in BMJ Open. The finding comes as a UN health summit in New York this week debates how to step up international efforts to...

2011-09-16 07:00:00

The product is a "smart cap" which, when added to a typical insulin pen, uses a timer to remind diabetics about when they're due for an insulin injection as reported by diabeticlive.com. Tampa, FL (PRWEB) September 16, 2011 âœSmart Capâ for Insulin Pens Reminds Diabetics When itâs Time for an Injection: Diabetics will soon have a new way to remind themselves to take insulin shots. A new product called Timesulin was recently announced at the...

2011-09-14 07:00:00

Most people don't know, however, that Lily was diagnosed with Type 1 diabetes at the age of three, and that her diabetes requires her to carefully manage her meals, her blood sugar levels, and her daily insulin injections as reported by diabeticlive.com. Tampa, FL (PRWEB) September 14, 2011 Amelia Lily, X-Factor Contestant, Discusses Her Type 1 Diabetes: Amelia Lily, a competitor on the British singing talent show X-Factor, recently received glowing praise from the judges for her rendition...

2011-09-12 23:30:17

Intranasal insulin therapy appears to provide some benefit for cognitive function in patients with amnestic mild cognitive impairment and Alzheimer disease, according to a report published Online First today by Archives of Neurology, one of the JAMA/Archives journals. According to background information in the article, insulin plays a role in a number of functions of the central nervous system. "The importance of insulin in normal brain function is underscored by evidence that insulin...

2011-09-11 07:00:00

A recent study that analyzed over 3,400 French adults over a period of 14 years found that those with Type 2 diabetes who received insulin treatment had a significantly increased risk of death as reported by diabeticlive.com. Tampa, FL (PRWEB) September 11, 2011 Insulin Treatment Associated with Higher Mortality Rates: A study that analyzed over 3,400 French adults over a period of 14 years found that those with Type 2 diabetes who received insulin treatment had a significantly increased...

2011-09-12 06:30:00

BRIDGEWATER, N.J., Sept. 12, 2011 /PRNewswire/ -- Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it has completed a significant Series C round of financing of $150 million. This financing will support the commercialization of the V-Go(TM) Disposable Insulin Delivery Device, which provides basal-bolus insulin therapy for adult patients with diabetes who require insulin. Welsh, Carson,...

2011-08-05 07:00:00

SAN DIEGO, Aug. 5, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today reported financial results for the second quarter of 2011 and discussed recent business progress. "We continue to execute on our business strategy, with strong progress this quarter," said Gregory I. Frost, Ph.D., Halozyme's...

2011-07-25 06:30:00

BRIDGEWATER, N.J., July 25, 2011 /PRNewswire/ -- Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it received CE Mark approval for its V-Go(TM) Disposable Insulin Delivery Device as well as ISO 13485: 2003 Quality Management System Certification. The V-Go is designed to provide simple basal-bolus therapy for adults who require insulin therapy. "These are important corporate milestones for...

2011-07-07 09:46:00

ORLANDO, Fla., July 7, 2011 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, and the advocacy organization Children with Diabetes, Inc. (CWD) today announced a two-year partnership to develop and distribute resources that will help newly diagnosed children with type 1 diabetes adjust to their new lifestyle. Every year, approximately 15,600 children and adolescents in the United States are diagnosed with type 1 diabetes, a condition that occurs when the body does not produce...


Latest Insulin therapy Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »